- ORCID iD
- 0000-0001-8554-280X
Show
Sort by
-
- Journal Article
- A1
- open access
Technical feasibility of [18F]FET and [18F]FAZA PET guided radiotherapy in a F98 glioblastoma rat model
-
- Journal Article
- A1
- open access
New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma
-
- Journal Article
- A1
- open access
The path toward PET-guided radiation therapy for glioblastoma in laboratory animals : a mini review
-
- Conference Paper
- C3
- open access
[18F]-FET and [18F]-FAZA PET guided irradiation of glioblastoma in rats
-
- Conference Paper
- C3
- open access
In vitro characterization of the amino acid PET tracer 2-[18F]FELP and in vivo comparison to [18F]FET and [18F]FDG in a F98 glioblastoma rat model
-
- Conference Paper
- C3
- open access
In vitro and in vivo evaluation of the LAT1 PET tracer 2-[18F]FELP in comparison to [18F]FET and [18F]FDG
-
- Journal Article
- A1
- open access
PET and MRI guided irradiation of a glioblastoma rat model using a micro-irradiator
-
PET for therapy response assessment in glioblastoma
-
- PhD Thesis
- open access
Assessment of therapy response and differentiation between tumor recurrence and therapy-related effects in high-grade glioma using PET and MRI
(2017) -
In vivo DCE-MRI for the discrimination between glioblastoma and radiation necrosis in rats
-
18F-FCho PET and MRI for the prediction of response in glioblastoma patients according to the RANO criteria
-
- Conference Paper
- C3
- open access
Evaluation of the LAT1 selective amino acid PET tracer 2-[18F]FELP in comparison to [18F]FET and [18F]FDG in a F98 glioblastoma rat model
-
- Journal Article
- A1
- open access
Kinetic modeling and graphical analysis of 18F-fluoromethylcholine (FCho), 18F-fluoroethyltyrosine (FET) and 18F-fluorodeoxyglucose (FDG) PET for the discrimination between high-grade glioma and radiation necrosis in rats
-
18F-fluoromethylcholine (FCho), 18F-fluoroethyltyrosine (FET), and 18F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study
-
F-18 fluoromethylcholine (F-18 FCho) PET for the prediction of response according to the RANO criteria in glioblastoma patients
-
18F-fluoromethylcholine (FCho), 18F-fluoroethylthyrosine (FET), 18F-fluordeoxyglucose (FDG) PET for the discrimination between high-grade glioma (HGG) and radiation necrosis (RN): a µPET study
-
Use of 18F-fluoromethylcholine PET in early treatment response assessment in glioblastoma patients
-
MRI-guided 3D conformal arc micro-irradiation of a F98 glioblastoma rat model using the Small Animal Radiation Research Platform (SARRP)
-
Molecular MRI in preclinical research
-
Targeting radiation-induced neuroinflammation using ICAM-MPIO
-
F-18 fluoromethylcholine (FCho), F-18 fluoroethyltyrosine (FET) and F-18 fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study
-
F-18 fluoromethylcholine (FCho), F-18 fluoroethyltyrosine (FET) and F-18 fluorodeoxyglucose (FDG) for the discrimination between tumor recurrence and radiation necrosis in high-grade glioma: a µPET study
-
Targeting radiation-induced neuroinflammation using ICAM-MPIO
-
Molecular MRI in preclinical research
-
In vivo magnetic resonance imaging of acute radiation induced inflammation using ICAM1 targeted micron-sized particles of iron oxide (ICAM-MPIO)
-
MRI-guided 3D-conformal arc micro-irradiation of a F98 glioblastoma rat model using a small animal radiation research platform
-
Structural and metabolic features of two different variants of multiple sclerosis : a PET/MRI study
-
The optimal timing for imaging brain tumours and other brain lesions with 18F-labelled fluoromethylcholine: a dynamic positron emission tomography study